ALECTOR INC. - COMMON STOCK

Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer

12 Dec 2025 16:05:00 By Nasdaq GlobeNewswire

Alector to Participate in the Bank of America CNS Therapeutics Conference

01 Dec 2025 16:05:00 By Nasdaq GlobeNewswire

Alector Reports Third Quarter 2025 Financial Results and Provides Business Update

06 Nov 2025 16:05:02 By Nasdaq GlobeNewswire

Alector Announces Topline Results from Latozinemab Phase 3 Trial in Individuals with Frontotemporal Dementia Due to a GRN Mutation and Provides Business Update

21 Oct 2025 16:06:35 By Nasdaq GlobeNewswire

Alector to Host Virtual Research and Development Event Highlighting PGRN Franchise and Brain Carrier Programs

16 Sep 2025 08:00:00 By Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

28 Aug 2025 08:00:00 By Nasdaq GlobeNewswire

Alector Reports Second Quarter 2025 Financial Results and Provides Business Update

07 Aug 2025 16:05:02 By Nasdaq GlobeNewswire

Alector to Host Second Quarter and Mid-Year 2025 Earnings Conference Call

31 Jul 2025 16:05:00 By Nasdaq GlobeNewswire

Alector Provides Executive Leadership Update

13 Jun 2025 16:05:00 By Nasdaq GlobeNewswire

Alector to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

03 Jun 2025 08:00:00 By Nasdaq GlobeNewswire

Alector Reports First Quarter 2025 Financial Results and Provides Business Update

08 May 2025 16:05:03 By Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

06 May 2025 08:00:02 By Nasdaq GlobeNewswire

Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease

17 Apr 2025 08:00:00 By Nasdaq GlobeNewswire

Alector Provides Executive Leadership Update

28 Mar 2025 16:05:00 By Nasdaq GlobeNewswire

Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

26 Feb 2025 16:05:00 By Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

25 Feb 2025 08:00:00 By Nasdaq GlobeNewswire

Alector to Host Fourth Quarter and Full-Year 2024 Earnings Conference Call

19 Feb 2025 16:05:00 By Nasdaq GlobeNewswire

Alector Reports on Recent Progress and Outlines Strategic Priorities for 2025

13 Jan 2025 08:00:00 By Nasdaq GlobeNewswire

Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business Update

25 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital

14 Nov 2024 16:05:46 By Nasdaq GlobeNewswire